88 related articles for article (PubMed ID: 7517020)
21. Vascular endothelial growth factor isoforms 121 and 165 are expressed on B-chronic lymphocytic leukemia cells.
Molica S; Santoro R; Digiesi G; Dattilo A; Levato D; Muleo G
Haematologica; 2000 Oct; 85(10):1106-8. PubMed ID: 11025612
[No Abstract] [Full Text] [Related]
22. Is lipoid nephrosis an "allergic" disease?
Lagrue G; Laurent J
Transplant Proc; 1982 Sep; 14(3):485-8. PubMed ID: 6217600
[No Abstract] [Full Text] [Related]
23. Nitric oxide in vascular endothelial growth factor synthesis and signaling.
Dulak J; Jozkowicz A
Circulation; 2001 Aug; 104(9):E48-9. PubMed ID: 11524413
[No Abstract] [Full Text] [Related]
24. Minimal change (steroid sensitive) nephrotic syndrome in children: new aspects on pathogenesis and treatment.
Oh J; Kemper MJ
Minerva Pediatr; 2012 Apr; 64(2):197-204. PubMed ID: 22495193
[TBL] [Abstract][Full Text] [Related]
25. [Hair follicles and vascular endothelial growth factor].
Lachgar S; Charvéron M; Aries MF; Gall Y; Bonafé JL
Ann Dermatol Venereol; 1998 Apr; 125(4):271-4. PubMed ID: 9747267
[No Abstract] [Full Text] [Related]
26. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.
Droller MJ
J Urol; 1998 Nov; 160(5):1932. PubMed ID: 9783988
[No Abstract] [Full Text] [Related]
27. [Advances in the study of the role of vascular endothelial growth factor and its receptor in tumor angiogenesis and its relation with anti-angiogenesis effect].
Bian X; Shi J
Zhonghua Bing Li Xue Za Zhi; 1997 Aug; 26(4):248-50. PubMed ID: 10072871
[No Abstract] [Full Text] [Related]
28. Vascular endothelial growth factor expression induced by proinflammatory cytokines (interleukin 1 alpha, beta) in cells of the human pilosebaceous unit.
Kozlowska U; Blume-Peytavi U; Kodelja V; Sommer C; Goerdt S; Jablonska S; Orfanos CE
Dermatology; 1998; 196(1):89-92. PubMed ID: 9557237
[No Abstract] [Full Text] [Related]
29. [Vascular endothelial growth factor. Its role in peritoneal physiopathology].
Selgas R; del Peso G; Bajo MA; Cirugeda A; Sánchez-Tomero JA; Alvarez V
Nefrologia; 2001; 21(5):423-5. PubMed ID: 11795005
[No Abstract] [Full Text] [Related]
30. Vascular endothelial growth factor as a target for antiangiogenic therapy.
Gordon MS
J Clin Oncol; 2000 Nov; 18(21 Suppl):45S-6S. PubMed ID: 11060326
[No Abstract] [Full Text] [Related]
31. Reply to Langer et al. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas.
Crazzolara R; Abrederis K; Kreczy A; Meister B
Med Pediatr Oncol; 2002 Aug; 39(2):146. PubMed ID: 12116069
[No Abstract] [Full Text] [Related]
32. FK 506 and cyclosporine inhibit antigen- or mitogen-induced monokine and lymphokine production in vitro.
Andersson J; Nagy S; Groth CG; Andersson U
Transplant Proc; 1992 Feb; 24(1):321-5. PubMed ID: 1371621
[No Abstract] [Full Text] [Related]
33. Cloning of VEGF165 into expression vector for protein production.
Tuffin MJ; Rakoczy PE; Lai MC; Papadimitriou JM; Constable IJ
Aust N Z J Ophthalmol; 1996 May; 24(2 Suppl):81-4. PubMed ID: 8811255
[No Abstract] [Full Text] [Related]
34. [The application of vascular endothelial growth factor in forensic science].
Li M; Liu M; Wang X; Liao ZG
Fa Yi Xue Za Zhi; 2001 Nov; 17(4):239-41. PubMed ID: 12533875
[TBL] [Abstract][Full Text] [Related]
35. [Advances in the treatment of adult nephrotic syndrome].
Yokoyama H; Asaka M; Yamaya H; Wada T
Nihon Jinzo Gakkai Shi; 2007; 49(2):108-12. PubMed ID: 17375618
[No Abstract] [Full Text] [Related]
36. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
Brown LF; Detmar M; Tognazzi K; Abu-Jawdeh G; Iruela-Arispe ML
Lab Invest; 1997 Feb; 76(2):245-55. PubMed ID: 9042161
[TBL] [Abstract][Full Text] [Related]
37. [Immunopathology of lipoid nephrosis].
Lagrue G; Laurent J; Belghiti D
Nephrologie; 1982; 3(1):40-5. PubMed ID: 7045715
[No Abstract] [Full Text] [Related]
38. Blockade of interleukin-2 production from cloned T cells by cyclosporine and FK 506 assessed by proliferation assays in vitro.
Matsuura T; Negita M; Ikegami M; Imanishi M; Nishioka T; Ishii T; Uemura T; Kunikata S; Kanda H; Akiyama T
Transplant Proc; 1992 Feb; 24(1):410-2. PubMed ID: 1371623
[No Abstract] [Full Text] [Related]
39. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma.
Suzuki K; Hayashi N; Miyamoto Y; Yamamoto M; Ohkawa K; Ito Y; Sasaki Y; Yamaguchi Y; Nakase H; Noda K; Enomoto N; Arai K; Yamada Y; Yoshihara H; Tujimura T; Kawano K; Yoshikawa K; Kamada T
Cancer Res; 1996 Jul; 56(13):3004-9. PubMed ID: 8674055
[TBL] [Abstract][Full Text] [Related]
40. [Demonstration of the angiogenic cytokine vascular endothelial growth factor (VEGF) by non radioactive in situ hybridization].
Strik MW; Laus C; Duchrow M; Broll R; Bruch HP
Ann Anat; 1997 Dec; 179(6):559-62. PubMed ID: 9480624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
